KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $111.1 million.

  • Medpace Holdings' Net Income towards Common Stockholders rose 1525.42% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.0 million, marking a year-over-year increase of 1841.63%. This contributed to the annual value of $404.4 million for FY2024, which is 4298.86% up from last year.
  • Latest data reveals that Medpace Holdings reported Net Income towards Common Stockholders of $111.1 million as of Q3 2025, which was up 1525.42% from $90.3 million recorded in Q2 2025.
  • Medpace Holdings' Net Income towards Common Stockholders' 5-year high stood at $117.0 million during Q4 2024, with a 5-year trough of $39.9 million in Q2 2021.
  • In the last 5 years, Medpace Holdings' Net Income towards Common Stockholders had a median value of $70.6 million in 2023 and averaged $75.3 million.
  • Examining YoY changes over the last 5 years, Medpace Holdings' Net Income towards Common Stockholders showed a top increase of 6567.37% in 2021 and a maximum decrease of 163.57% in 2021.
  • Medpace Holdings' Net Income towards Common Stockholders (Quarter) stood at $50.0 million in 2021, then skyrocketed by 37.25% to $68.7 million in 2022, then rose by 14.02% to $78.3 million in 2023, then surged by 49.45% to $117.0 million in 2024, then decreased by 5.03% to $111.1 million in 2025.
  • Its Net Income towards Common Stockholders stands at $111.1 million for Q3 2025, versus $90.3 million for Q2 2025 and $114.6 million for Q1 2025.